p53 regulates Myogenesis by triggering the differentiation activity of pRb

被引:99
作者
Porrello, A [1 ]
Cerone, MA [1 ]
Coen, S [1 ]
Gurtner, A [1 ]
Fontemaggi, G [1 ]
Cimino, L [1 ]
Piaggio, G [1 ]
Sacchi, A [1 ]
Soddu, S [1 ]
机构
[1] Regina Elena Inst Canc Res, Mol Oncogenesis Lab, Ctr Expt Res, I-00158 Rome, Italy
关键词
p53; Rb; MyoD; differentiation; muscle;
D O I
10.1083/jcb.151.6.1295
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The p53 oncosuppressor protein regulates cell cycle checkpoints and apoptosis, but increasing evidence also indicates its involvement in differentiation and development. We had previously demonstrated that in the presence of differentiation-promoting stimuli, p53-defective myoblasts exit from the cell cycle but do not differentiate into myocytes and myotubes. To identify the pathways through which p53 contributes to skeletal muscle differentiation, we have analyzed the expression of a series of genes regulated during myogenesis in parental and dominant-negative p53 (dnp53)-expressing C2C12 myoblasts. We found that in dnp53-expressing C2C12 cells, as well as in p53(-/-) primary myoblasts, pRb is hypophosphorylated and proliferation stops. However, these cells do not upregulate pRb and have reduced MyoD activity. The transduction of exogenous TP53 or Rb genes in p53-defective myoblasts rescues MyoD activity and differentiation potential, Additionally, in vivo studies on the Rb promoter demonstrate that p53 regulates the Rb gene expression at transcriptional level through a p53-binding site, Therefore, here we show that p53 regulates myoblast differentiation by means of pRb without affecting its cell cycle-related functions.
引用
收藏
页码:1295 / 1303
页数:9
相关论文
共 54 条
[1]   Involvement of p53 in cell differentiation and development [J].
Almog, N ;
Rotter, V .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (01) :F1-F27
[2]   TESTICULAR TISSUE-SPECIFIC EXPRESSION OF THE P53 SUPPRESSOR GENE [J].
ALMON, E ;
GOLDFINGER, N ;
KAPON, A ;
SCHWARTZ, D ;
LEVINE, AJ ;
ROTTER, V .
DEVELOPMENTAL BIOLOGY, 1993, 156 (01) :107-116
[3]   HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[4]  
AUSBEL FM, 1987, CURRENT PROTOCOLS MO, V1
[5]  
BACCHETTI S, 1993, INT J ONCOL, V3, P781
[6]   IMMUNOCHEMICAL ANALYSIS OF MYOSIN HEAVY-CHAIN DURING AVIAN MYOGENESIS INVIVO AND INVITRO [J].
BADER, D ;
MASAKI, T ;
FISCHMAN, DA .
JOURNAL OF CELL BIOLOGY, 1982, 95 (03) :763-770
[7]   Development of a murine orthotopic model of leukemia:: Evaluation of TP53 gene therapy efficacy [J].
Bossi, G ;
Scardigli, R ;
Musiani, P ;
Martinelli, R ;
Gentileschi, MP ;
Soddu, S ;
Sacchi, A .
CANCER GENE THERAPY, 2000, 7 (01) :135-143
[8]   c-Myc target gene specificity is determined by a post-DNA-binding mechanism [J].
Boyd, KE ;
Wells, J ;
Gutman, J ;
Bartley, SM ;
Farnham, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13887-13892
[9]   p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts [J].
M A Cerone ;
A Marchetti ;
G Bossi ;
G Blandino ;
A Sacchi ;
S Soddu .
Cell Death & Differentiation, 2000, 7 (5) :506-508
[10]   CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT [J].
CHANG, MW ;
BARR, E ;
SELTZER, J ;
JIANG, YQ ;
NABEL, GJ ;
NABEL, EG ;
PARMACEK, MS ;
LEIDEN, JM .
SCIENCE, 1995, 267 (5197) :518-522